Jonathan Miller interviews Rayetta Henderson, Senior Managing Scientist at Tox Strategies about her research and her testimony before the House Oversight Committee on the safety of hemp-derived CBD. If you have questions about the episode or ideas for Hemp related topics, email us at [email protected].

Hemp Industry questions covered in the episode: 

1. What were the results of your toxicology studies on the safety of CBD isolate?
2. How were thise results different from the studies championed by FDA concerning pharmaceutical-grade CBD found in the prescription drug Epidiolex?
3. Why are studies of rodents applicable to the experience of humans?
4. Have there been enough studies of CBD for FDA or Congress to be able to establish appropriate limits if CBD in dietary supplements and food/beverage?
5. What counsel to you give to Congress as they go about the process of drafting legislation to regulate CBD?